Search

Your search keyword '"Gerstner S"' showing total 3 results
Start Over Author "Gerstner S" Journal klinische padiatrie
3 results on '"Gerstner S"'

1. Der Methylphenidat-Doppelblindversuch - Indikation und Durchführung

Author

Becker K, Bliznakova L, Gerstner S, and Schmidt Mh

Subjects
medicine.medical_specialty, Treatment system, business.industry, Methylphenidate, Impulsivity, medicine.disease, Trial Indication, Hyperkinetic disorder, Double blind, Pediatrics, Perinatology and Child Health, Psychiatric diagnosis, Medicine, In patient, medicine.symptom, business, Psychiatry, medicine.drug
Abstract

Hyperkinetic disorders or attention-deficit/hyperactivity disorders (ADHD) are among the psychiatric diagnoses most often encountered in children and adolescents. Symptoms include inattention, hyperactivity and impulsivity. Within the multi-modal treatment system, the therapy with psychostimulants (e. g. methylphenidate) proved to be an effective in patients with ADHD. A double-blind trial is indicated in cases of unclear efficacy of methylphenidate at initial application or if psychostimulants have regularly been applied for more than one year with an leave-out trial delivering unequivocal results. Further it is helpful in verifying potential undesirable side effects and improving patients' compliance.

Published
2007

3. [Methylphenidate double-blind trial: indication and performing].

Author

Bliznakova L, Gerstner S, Schmidt MH, and Becker K

Subjects
Adolescent, Central Nervous System Stimulants adverse effects, Child, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hospitalization, Humans, Male, Methylphenidate adverse effects, Randomized Controlled Trials as Topic, Treatment Outcome, Attention Deficit Disorder with Hyperactivity drug therapy, Central Nervous System Stimulants therapeutic use, Methylphenidate therapeutic use
Abstract

Hyperkinetic disorders or attention-deficit/hyperactivity disorders (ADHD) are among the psychiatric diagnoses most often encountered in children and adolescents. Symptoms include inattention, hyperactivity and impulsivity. Within the multi-modal treatment system, the therapy with psychostimulants (e. g. methylphenidate) proved to be an effective in patients with ADHD. A double-blind trial is indicated in cases of unclear efficacy of methylphenidate at initial application or if psychostimulants have regularly been applied for more than one year with an leave-out trial delivering unequivocal results. Further it is helpful in verifying potential undesirable side effects and improving patients' compliance.

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results